IDEXX LABORATORIES INC (1IDXX.MI) Fundamental Analysis & Valuation

BIT:1IDXX • US45168D1046

Current stock price

554.8 EUR
+20.6 (+3.86%)
Last:

This 1IDXX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1IDXX.MI Profitability Analysis

1.1 Basic Checks

  • 1IDXX had positive earnings in the past year.
  • In the past year 1IDXX had a positive cash flow from operations.
  • 1IDXX had positive earnings in each of the past 5 years.
  • In the past 5 years 1IDXX always reported a positive cash flow from operatings.
1IDXX.MI Yearly Net Income VS EBIT VS OCF VS FCF1IDXX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • 1IDXX's Return On Assets of 29.59% is amongst the best of the industry. 1IDXX outperforms 98.46% of its industry peers.
  • Looking at the Return On Equity, with a value of 67.56%, 1IDXX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Invested Capital of 1IDXX (37.30%) is better than 98.46% of its industry peers.
  • 1IDXX had an Average Return On Invested Capital over the past 3 years of 35.08%. This is significantly above the industry average of 9.72%.
  • The 3 year average ROIC (35.08%) for 1IDXX is below the current ROIC(37.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.59%
ROE 67.56%
ROIC 37.3%
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
1IDXX.MI Yearly ROA, ROE, ROIC1IDXX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • Looking at the Profit Margin, with a value of 24.41%, 1IDXX belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1IDXX has grown nicely.
  • 1IDXX's Operating Margin of 31.09% is amongst the best of the industry. 1IDXX outperforms 98.46% of its industry peers.
  • In the last couple of years the Operating Margin of 1IDXX has grown nicely.
  • 1IDXX has a better Gross Margin (61.54%) than 61.54% of its industry peers.
  • In the last couple of years the Gross Margin of 1IDXX has remained more or less at the same level.
Industry RankSector Rank
OM 31.09%
PM (TTM) 24.41%
GM 61.54%
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.55%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
1IDXX.MI Yearly Profit, Operating, Gross Margins1IDXX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. 1IDXX.MI Health Analysis

2.1 Basic Checks

  • 1IDXX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1IDXX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, 1IDXX has less shares outstanding
  • 1IDXX has a better debt/assets ratio than last year.
1IDXX.MI Yearly Shares Outstanding1IDXX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
1IDXX.MI Yearly Total Debt VS Total Assets1IDXX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 21.40 indicates that 1IDXX is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 21.40, 1IDXX belongs to the top of the industry, outperforming 96.92% of the companies in the same industry.
  • The Debt to FCF ratio of 1IDXX is 1.43, which is an excellent value as it means it would take 1IDXX, only 1.43 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1IDXX (1.43) is better than 83.08% of its industry peers.
  • A Debt/Equity ratio of 0.71 indicates that 1IDXX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 1IDXX (0.71) is worse than 73.85% of its industry peers.
  • Although 1IDXX's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 1.43
Altman-Z 21.4
ROIC/WACC3.54
WACC10.54%
1IDXX.MI Yearly LT Debt VS Equity VS FCF1IDXX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • 1IDXX has a Current Ratio of 1.11. This is a normal value and indicates that 1IDXX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.11, 1IDXX is doing worse than 69.23% of the companies in the same industry.
  • A Quick Ratio of 0.79 indicates that 1IDXX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.79, 1IDXX is doing worse than 69.23% of the companies in the same industry.
  • The current and quick ratio evaluation for 1IDXX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
1IDXX.MI Yearly Current Assets VS Current Liabilites1IDXX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. 1IDXX.MI Growth Analysis

3.1 Past

  • 1IDXX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.45%, which is quite good.
  • Measured over the past years, 1IDXX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.18% on average per year.
  • Looking at the last year, 1IDXX shows a small growth in Revenue. The Revenue has grown by 6.68% in the last year.
  • Measured over the past years, 1IDXX shows a quite strong growth in Revenue. The Revenue has been growing by 10.12% on average per year.
EPS 1Y (TTM)12.45%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%20.2%
Revenue 1Y (TTM)6.68%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%10.55%

3.2 Future

  • Based on estimates for the next years, 1IDXX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.68% on average per year.
  • The Revenue is expected to grow by 8.69% on average over the next years. This is quite good.
EPS Next Y14.22%
EPS Next 2Y13.24%
EPS Next 3Y13.08%
EPS Next 5Y11.68%
Revenue Next Year9.07%
Revenue Next 2Y8.66%
Revenue Next 3Y8.62%
Revenue Next 5Y8.69%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
1IDXX.MI Yearly Revenue VS Estimates1IDXX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
1IDXX.MI Yearly EPS VS Estimates1IDXX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1IDXX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 53.35, which means the current valuation is very expensive for 1IDXX.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1IDXX indicates a slightly more expensive valuation: 1IDXX is more expensive than 60.00% of the companies listed in the same industry.
  • 1IDXX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.23.
  • Based on the Price/Forward Earnings ratio of 44.41, the valuation of 1IDXX can be described as expensive.
  • 66.15% of the companies in the same industry are cheaper than 1IDXX, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.28. 1IDXX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 53.35
Fwd PE 44.41
1IDXX.MI Price Earnings VS Forward Price Earnings1IDXX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1IDXX indicates a slightly more expensive valuation: 1IDXX is more expensive than 66.15% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1IDXX.
Industry RankSector Rank
P/FCF 66.19
EV/EBITDA 37.05
1IDXX.MI Per share data1IDXX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1IDXX does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1IDXX may justify a higher PE ratio.
  • 1IDXX's earnings are expected to grow with 13.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.75
PEG (5Y)2.93
EPS Next 2Y13.24%
EPS Next 3Y13.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1IDXX.MI Dividend Analysis

5.1 Amount

  • 1IDXX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1IDXX.MI Fundamentals: All Metrics, Ratios and Statistics

IDEXX LABORATORIES INC

BIT:1IDXX (3/3/2026, 7:00:00 PM)

554.8

+20.6 (+3.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02
Earnings (Next)04-29
Inst Owners95.39%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap44.17B
Revenue(TTM)4.04B
Net Income(TTM)985.66M
Analysts80.91
Price Target652.73 (17.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.76%
Min EPS beat(2)1.72%
Max EPS beat(2)7.81%
EPS beat(4)4
Avg EPS beat(4)4.73%
Min EPS beat(4)1.72%
Max EPS beat(4)7.81%
EPS beat(8)8
Avg EPS beat(8)4.6%
EPS beat(12)12
Avg EPS beat(12)4.41%
EPS beat(16)14
Avg EPS beat(16)3.9%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)1.88%
Revenue beat(4)2
Avg Revenue beat(4)-0.58%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.88%
Revenue beat(8)2
Avg Revenue beat(8)-1.32%
Revenue beat(12)2
Avg Revenue beat(12)-1.2%
Revenue beat(16)3
Avg Revenue beat(16)-1.19%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 53.35
Fwd PE 44.41
P/S 12.69
P/FCF 66.19
P/OCF 56.58
P/B 35.13
P/tB 54.49
EV/EBITDA 37.05
EPS(TTM)10.4
EY1.87%
EPS(NY)12.49
Fwd EY2.25%
FCF(TTM)8.38
FCFY1.51%
OCF(TTM)9.81
OCFY1.77%
SpS43.71
BVpS15.79
TBVpS10.18
PEG (NY)3.75
PEG (5Y)2.93
Graham Number60.79
Profitability
Industry RankSector Rank
ROA 29.59%
ROE 67.56%
ROCE 59.57%
ROIC 37.3%
ROICexc 39.73%
ROICexgc 50.01%
OM 31.09%
PM (TTM) 24.41%
GM 61.54%
FCFM 19.18%
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
ROICexc(3y)39.8%
ROICexc(5y)41.54%
ROICexgc(3y)51.52%
ROICexgc(5y)54.69%
ROCE(3y)52.73%
ROCE(5y)50.92%
ROICexgc growth 3Y-5.99%
ROICexgc growth 5Y4.29%
ROICexc growth 3Y-3.86%
ROICexc growth 5Y4.07%
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.55%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
F-Score7
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 1.43
Debt/EBITDA 0.74
Cap/Depr 95.5%
Cap/Sales 3.26%
Interest Coverage 250
Cash Conversion 65.03%
Profit Quality 78.56%
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 21.4
F-Score7
WACC10.54%
ROIC/WACC3.54
Cap/Depr(3y)119.66%
Cap/Depr(5y)117.12%
Cap/Sales(3y)3.91%
Cap/Sales(5y)3.89%
Profit Quality(3y)79.31%
Profit Quality(5y)83.23%
High Growth Momentum
Growth
EPS 1Y (TTM)12.45%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%20.2%
EPS Next Y14.22%
EPS Next 2Y13.24%
EPS Next 3Y13.08%
EPS Next 5Y11.68%
Revenue 1Y (TTM)6.68%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%10.55%
Revenue Next Year9.07%
Revenue Next 2Y8.66%
Revenue Next 3Y8.62%
Revenue Next 5Y8.69%
EBIT growth 1Y15.86%
EBIT growth 3Y6.64%
EBIT growth 5Y15.38%
EBIT Next Year31.91%
EBIT Next 3Y16.8%
EBIT Next 5Y14.07%
FCF growth 1Y30.65%
FCF growth 3Y7.86%
FCF growth 5Y21.29%
OCF growth 1Y21.32%
OCF growth 3Y7.13%
OCF growth 5Y15.13%

IDEXX LABORATORIES INC / 1IDXX.MI Fundamental Analysis FAQ

What is the fundamental rating for 1IDXX stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1IDXX.MI.


What is the valuation status of IDEXX LABORATORIES INC (1IDXX.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to IDEXX LABORATORIES INC (1IDXX.MI). This can be considered as Overvalued.


What is the profitability of 1IDXX stock?

IDEXX LABORATORIES INC (1IDXX.MI) has a profitability rating of 9 / 10.


What is the financial health of IDEXX LABORATORIES INC (1IDXX.MI) stock?

The financial health rating of IDEXX LABORATORIES INC (1IDXX.MI) is 8 / 10.